|
FR580494A
(fr)
|
1923-07-10 |
1924-11-07 |
Const Metalliques Schiltigheim |
Procédé d'établissement des buses d'aération ou autres tuyaux
|
|
US2837464A
(en)
*
|
1955-01-11 |
1958-06-03 |
Schering Corp |
Process for production of dienes by corynebacteria
|
|
DE1059906B
(de)
|
1954-10-05 |
1959-06-25 |
Scherico Ltd |
Verfahren zur Herstellung von 1, 4-Pregnadienen
|
|
US3067197A
(en)
|
1961-04-26 |
1962-12-04 |
Pfizer & Co C |
11-oxygenated 6alpha-fluoro-16-methylene-delta-pregnenes and derivatives
|
|
GB1047518A
(en)
*
|
1963-06-11 |
1966-11-02 |
Glaxo Lab Ltd |
17ª-monoesters of 11,17,21-trihydroxy steroid compounds
|
|
GB1159490A
(en)
*
|
1966-02-09 |
1969-07-23 |
Boots Pure Drug Co Ltd |
Improvements in Acylated Steroids
|
|
US3639434A
(en)
|
1967-02-02 |
1972-02-01 |
Boots Pure Drug Co Ltd |
17-acyloxysteroids and their manufacture
|
|
IT1061787B
(it)
|
1967-03-01 |
1983-04-30 |
Vismara Francesco Spa |
Miglioramenti relativi alla preparazione di 17 benzoato di betametazone
|
|
GB1227992A
(OSRAM)
|
1968-01-23 |
1971-04-15 |
Koninklijke Gist Spiritus |
|
|
US3557694A
(en)
*
|
1969-04-21 |
1971-01-26 |
Burroughs Corp |
Print head latching mechanism
|
|
IT1034011B
(it)
*
|
1969-06-26 |
1979-09-10 |
Vister Vismara Terapeutici S P |
Processo per la prapratzione di 17 monoesteri di 17 a 21 diossisteroidi per idrolisi die corpispondenti 17 21 ortoesteri ciclici a ph control lato
|
|
GB1384372A
(en)
|
1971-01-20 |
1975-02-19 |
Glaxo Lab Ltd |
Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids
|
|
US3828080A
(en)
|
1972-01-20 |
1974-08-06 |
Glaxo Lab Ltd |
Androstane-17beta-carboxylic acids and processes for the preparation thereof
|
|
US3989686A
(en)
|
1972-06-15 |
1976-11-02 |
Glaxo Laboratories Limited |
Anaesthetic steroids of the androstane series and process for preparing same
|
|
GB1438940A
(en)
|
1972-07-19 |
1976-06-09 |
Glaxo Lab Ltd |
17beta-haloalkoxycarbonyl-17alpha-oxysteroids
|
|
GB1440063A
(en)
*
|
1972-08-11 |
1976-06-23 |
Glaxo Lab Ltd |
17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids
|
|
US3881894A
(en)
*
|
1972-10-05 |
1975-05-06 |
George R Onufer |
Vapor emission control system and method
|
|
DE2336693A1
(de)
|
1973-07-19 |
1975-02-06 |
Nassheuer Ind Ofenbau Jean |
Strahlheizrohr
|
|
US4093721A
(en)
|
1974-08-30 |
1978-06-06 |
Glaxo Laboratories Limited |
Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof
|
|
GB1517278A
(en)
|
1974-08-30 |
1978-07-12 |
Glaxo Lab Ltd |
Alkyl and haloalkyl androsta-1,4,15-triene and-4,15-diene-17beta-carboxylates
|
|
US3969686A
(en)
*
|
1975-03-26 |
1976-07-13 |
Xerox Corporation |
Beam collimation using multiple coupled elements
|
|
YU54476A
(en)
*
|
1975-03-31 |
1982-05-31 |
Taisho Pharmaceutical Co Ltd |
Process for obtaining 17-ester 21-halo-pregnane
|
|
DE2538569A1
(de)
|
1975-08-29 |
1977-03-03 |
Siemens Ag |
Verfahren zur metallisierung von duroplasten
|
|
CH628355A5
(de)
|
1976-02-24 |
1982-02-26 |
Ciba Geigy Ag |
Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze.
|
|
US4221787A
(en)
*
|
1978-03-28 |
1980-09-09 |
Interx Research Corporation |
Esteramide prodrugs of anti-inflammatory corticosteroids
|
|
US4198403A
(en)
|
1978-04-05 |
1980-04-15 |
Syntex (U.S.A.) Inc. |
17 Beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes
|
|
US4263289A
(en)
|
1978-04-05 |
1981-04-21 |
Syntex (U.S.A.) Inc. |
Thio etianic acid derivatives
|
|
US4187301A
(en)
|
1978-04-05 |
1980-02-05 |
Syntex (U.S.A.) Inc. |
17 Beta-thiocarboxylic acid esters of 6 alpha, 6 beta-difluoro-3-oxoandrost-4-enes
|
|
US4188385A
(en)
|
1978-04-05 |
1980-02-12 |
Syntex (U.S.A.) Inc. |
Thioetianic acid derivatives
|
|
US4261984A
(en)
|
1978-04-05 |
1981-04-14 |
Syntex (U.S.A.) Inc. |
17β-thiocarboxylic acid esters of 3-oxo-4-halo-16β-methylandrost-4-enes
|
|
DE2817988A1
(de)
*
|
1978-04-25 |
1979-11-08 |
Hoechst Ag |
Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
|
|
US4310466A
(en)
|
1979-08-31 |
1982-01-12 |
Syntex (U.S.A.) Inc. |
Thio etianic acid derivatives
|
|
US4267173A
(en)
|
1979-11-05 |
1981-05-12 |
Schering Corporation |
Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
|
|
US4377389A
(en)
|
1979-12-12 |
1983-03-22 |
Foster Grant Corporation |
Dip dyeing of plastic articles and the dye bath composition thereof
|
|
CY1291A
(en)
|
1980-02-15 |
1985-10-18 |
Glaxo Group Ltd |
Androstane 17 beta carbothioates
|
|
BE887518A
(fr)
|
1980-02-15 |
1981-08-13 |
Glaxo Group Ltd |
Cartothioates d'androstanes
|
|
US4710495A
(en)
|
1980-07-10 |
1987-12-01 |
Otsuka Pharmaceutical Co., Ltd. |
Soft steroids having anti-inflammatory activity
|
|
SE449106B
(sv)
|
1980-07-10 |
1987-04-06 |
Otsuka Pharma Co Ltd |
Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
|
|
US4996335A
(en)
|
1980-07-10 |
1991-02-26 |
Nicholas S. Bodor |
Soft steroids having anti-inflammatory activity
|
|
ZA814440B
(en)
|
1980-07-10 |
1982-10-27 |
Otsuka Pharma Co Ltd |
Soft steroids having anti-inflammatory activity
|
|
CY1359A
(en)
|
1981-02-02 |
1987-08-07 |
Schering Corp |
Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
|
|
ZW6584A1
(en)
|
1983-04-18 |
1985-04-17 |
Glaxo Group Ltd |
Phenethanolamine derivatives
|
|
US4607028A
(en)
|
1983-08-18 |
1986-08-19 |
Ciba-Geigy Corporation |
Novel carboxylic acid esters
|
|
EP0179583A1
(en)
|
1984-10-04 |
1986-04-30 |
Merck & Co. Inc. |
A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
|
|
US4861765A
(en)
|
1985-06-26 |
1989-08-29 |
Jouveinal |
21-alkyl-, cycloalkyl- or aryl-substituted thio steroids and pharmaceutical compositions containing them
|
|
ZA872389B
(en)
|
1987-04-02 |
1987-11-25 |
Advanced Polymer Systems Inc |
Composition and method for delivering a steroid active ingredient
|
|
US4964069A
(en)
|
1987-05-12 |
1990-10-16 |
International Business Machines Corporation |
Self adjusting video interface
|
|
EP0334853B1
(en)
|
1987-10-13 |
1993-06-09 |
BODOR, Nicholas S. |
Soft steroids having anti-inflammatory activity
|
|
US4994439A
(en)
|
1989-01-19 |
1991-02-19 |
California Biotechnology Inc. |
Transmembrane formulations for drug administration
|
|
FR2644788B1
(fr)
*
|
1989-03-22 |
1995-02-03 |
Roussel Uclaf |
Nouveaux steroides 3-ceto comportant une chaine en 17 amino-substituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
|
|
US5202316A
(en)
*
|
1989-03-22 |
1993-04-13 |
Roussel Uclaf |
N,N,N',N'-6-(1-piperazinyl)-2,5-pyridinediamines
|
|
JPH07116215B2
(ja)
*
|
1989-04-19 |
1995-12-13 |
エスエス製薬株式会社 |
新規なステロイド化合物
|
|
WO1990015816A1
(en)
|
1989-06-16 |
1990-12-27 |
The Upjohn Company |
Suramin type compounds and angiostatic steroids to inhibit angiogenesis
|
|
IL95590A
(en)
|
1989-09-08 |
1996-06-18 |
Glaxo Group Ltd |
Medicinal preparations containing Salmetrol and Pluticasone Propionate
|
|
DE3931041C2
(de)
|
1989-09-16 |
2000-04-06 |
Boehringer Ingelheim Kg |
Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
|
|
DE4025342A1
(de)
*
|
1990-08-10 |
1992-02-13 |
Hoechst Ag |
In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel
|
|
JP3087763B2
(ja)
|
1990-11-30 |
2000-09-11 |
三井化学株式会社 |
新規な複素環式化合物およびそれを含有する医薬組成物
|
|
ES2187500T3
(es)
|
1991-02-21 |
2003-06-16 |
Smithkline Beecham Corp |
Uso de topotecano en el tratamiento del carcinoma pulmonar no de celulas pequeñas.
|
|
GB9103764D0
(en)
|
1991-02-22 |
1991-04-10 |
Glaxo Group Ltd |
Compositions
|
|
US5250293A
(en)
|
1991-04-22 |
1993-10-05 |
Gleich Gerald J |
Method for the treatment of hypersensitivity diseases by administration of anionic polymers
|
|
TW247878B
(OSRAM)
|
1991-07-02 |
1995-05-21 |
Takeda Pharm Industry Co Ltd |
|
|
US6127353A
(en)
|
1991-09-06 |
2000-10-03 |
Schering Corporation |
Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
|
|
US5658549A
(en)
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
|
KR100321649B1
(ko)
|
1993-03-17 |
2002-07-22 |
미네소타 마이닝 앤드 매뉴팩춰링 캄파니 |
에스테르,아미드또는머캅토에스테르로부터유도된분산보조제를함유하는에어로졸제제
|
|
DE4328819A1
(de)
|
1993-08-27 |
1995-03-02 |
Hoechst Ag |
Corticosteroid-17-alkylcarbonat-21/0/-Carbonsäure- und Kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
|
|
DE4333920A1
(de)
|
1993-10-05 |
1995-04-13 |
Hoechst Ag |
Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
|
|
US5420120A
(en)
|
1993-12-17 |
1995-05-30 |
Alcon Laboratories, Inc. |
Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
|
|
US5837699A
(en)
|
1994-01-27 |
1998-11-17 |
Schering Corporation |
Use of mometasone furoate for treating upper airway passage diseases
|
|
IL109656A
(en)
|
1994-05-15 |
1998-02-22 |
Chemagis Ltd |
Process for the manufacture of androstane - 17 - carbothioates and androstane - 17 - carbothioates prepared thereby
|
|
GB9410222D0
(en)
|
1994-05-21 |
1994-07-06 |
Glaxo Wellcome Australia Ltd |
Medicaments
|
|
GB9419536D0
(en)
|
1994-09-28 |
1994-11-16 |
Glaxo Inc |
Medicaments
|
|
SA95160463B1
(ar)
|
1994-12-22 |
2005-10-04 |
استرا أكتيبولاج |
مساحيق للاستنشاق
|
|
JPH08291072A
(ja)
|
1995-04-22 |
1996-11-05 |
Kissei Pharmaceut Co Ltd |
吸入用粉末製剤用結晶とその製造方法
|
|
JPH08291073A
(ja)
|
1995-04-22 |
1996-11-05 |
Kissei Pharmaceut Co Ltd |
医薬品組成物及びその製造方法
|
|
DE19528145A1
(de)
|
1995-08-01 |
1997-02-06 |
Boehringer Ingelheim Kg |
Neue Arzneimittel und ihre Verwendung
|
|
GB9521696D0
(en)
|
1995-10-23 |
1996-01-03 |
Bayer Ag |
Combination of LTD4 receptor antagonists with glucocorticosteriods
|
|
US5766620A
(en)
|
1995-10-23 |
1998-06-16 |
Theratech, Inc. |
Buccal delivery of glucagon-like insulinotropic peptides
|
|
US5707984A
(en)
|
1995-12-08 |
1998-01-13 |
G. D. Searle & Co. |
Steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs
|
|
US5792758A
(en)
|
1995-12-08 |
1998-08-11 |
G. D. Searle & Co. |
Steroid nitrite ester derivatives useful as anti-inflammatory drugs
|
|
EE9800227A
(et)
|
1995-12-29 |
1998-12-15 |
Glaxo Group Limited |
17ß-karboksü-, karbotio- ja amiidandrostaanide laktoonderivaadid
|
|
US5985862A
(en)
|
1996-05-02 |
1999-11-16 |
G.D. Searle & Co. |
Pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
|
|
US5981517A
(en)
|
1996-05-09 |
1999-11-09 |
Soft Drugs, Inc. |
Androstene derivatives
|
|
AU3153797A
(en)
|
1996-06-04 |
1998-01-05 |
Procter & Gamble Company, The |
A nasal spray containing an intranasal steroid and an antihistamine
|
|
GB9622173D0
(en)
*
|
1996-10-24 |
1996-12-18 |
Glaxo Group Ltd |
Particulate Products
|
|
US5919776A
(en)
|
1996-12-20 |
1999-07-06 |
Merck & Co., Inc. |
Substituted aminoquinolines as modulators of chemokine receptor activity
|
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
|
AU6496498A
(en)
|
1997-02-07 |
1998-08-26 |
Gist-Brocades B.V. |
Homogeneous granulated formulations for dose sipping technology
|
|
PT1493439E
(pt)
|
1997-04-02 |
2012-01-10 |
Brigham & Womens Hospital |
Meio de avaliação do perfil de risco de um indivíduo para uma doença aterosclerótica
|
|
ATE260931T1
(de)
|
1997-06-30 |
2004-03-15 |
Glaxo Group Ltd |
Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität
|
|
SE9704186D0
(sv)
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New composition of matter
|
|
SE9704833D0
(sv)
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New formulation
|
|
US5972920A
(en)
|
1998-02-12 |
1999-10-26 |
Dermalogix Partners, Inc. |
Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
|
|
US6506766B1
(en)
|
1998-02-13 |
2003-01-14 |
Abbott Laboratories |
Glucocortiocoid-selective antinflammatory agents
|
|
US6136294C1
(en)
|
1998-09-22 |
2002-09-24 |
Aeropharm Technology Inc |
Amino acid stabilized medical aerosol formulation
|
|
US6458338B1
(en)
*
|
1998-09-22 |
2002-10-01 |
Aeropharm Technology Incorporated |
Amino acid stabilized medicinal aerosol formulations
|
|
US6261539B1
(en)
|
1998-12-10 |
2001-07-17 |
Akwete Adjei |
Medicinal aerosol formulation
|
|
AU1687400A
(en)
*
|
1998-12-17 |
2000-07-03 |
Sony Computer Entertainment Inc. |
Apparatus and method for generating music data
|
|
GB9828721D0
(en)
|
1998-12-24 |
1999-02-17 |
Glaxo Group Ltd |
Novel apparatus and process
|
|
AU3703900A
(en)
|
1999-02-24 |
2000-09-14 |
Nitromed, Inc. |
Nitrosated and nitrosylated steroids for the treatment of cardiovascular diseases and disorders
|
|
AU3411000A
(en)
|
1999-03-24 |
2000-10-09 |
Glenayre Electronics, Inc |
Computation and quantization of voiced excitation pulse shapes in linear predictive coding of speech
|
|
HRP20010804B1
(en)
|
1999-04-30 |
2006-05-31 |
Pfizer Products Inc. |
Glucocorticoid receptor modulators
|
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
GB9918559D0
(en)
*
|
1999-08-07 |
1999-10-06 |
Glaxo Wellcome Kk |
Novel pharmaceutical formulation
|
|
US20020081266A1
(en)
*
|
1999-08-20 |
2002-06-27 |
Norton Healthcare Ltd. |
Spray dried powders for pulmonary or nasal administration
|
|
AU782386C
(en)
|
1999-08-31 |
2006-08-10 |
Brigham And Women's Hospital |
Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases
|
|
AU7703400A
(en)
|
1999-09-14 |
2001-04-17 |
Xenoport, Inc. |
Substrates and screening methods for transport proteins
|
|
US6596261B1
(en)
|
2000-01-25 |
2003-07-22 |
Aeropharm Technology Incorporated |
Method of administering a medicinal aerosol formulation
|
|
WO2001054481A2
(en)
|
2000-01-28 |
2001-08-02 |
Rohm And Haas Company |
Enhanced propertied pharmaceuticals
|
|
US20020133032A1
(en)
|
2000-02-25 |
2002-09-19 |
Jufang Barkalow |
Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
|
|
GB0009591D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Medical combinations
|
|
GB0009592D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Respiratory combinations
|
|
GB0009583D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Respiratory formulations
|
|
GB0009606D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Therapeutic combinations
|
|
GB0015876D0
(en)
*
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
|
GB0016040D0
(en)
|
2000-06-29 |
2000-08-23 |
Glaxo Group Ltd |
Novel process for preparing crystalline particles
|
|
GB0017988D0
(en)
|
2000-07-21 |
2000-09-13 |
Glaxo Group Ltd |
Novel process
|
|
CA2412376A1
(en)
|
2000-07-26 |
2002-01-31 |
Onkar N. Singh |
Pharmaceutical suspension compositions lacking a polymeric suspending agent
|
|
US6858596B2
(en)
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivative
|
|
US6777399B2
(en)
*
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
US6777400B2
(en)
*
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
US6750210B2
(en)
|
2000-08-05 |
2004-06-15 |
Smithkline Beecham Corporation |
Formulation containing novel anti-inflammatory androstane derivative
|
|
US6858593B2
(en)
*
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
US6759398B2
(en)
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
|
AU7576001A
(en)
|
2000-08-05 |
2002-02-18 |
Glaxo Group Ltd |
6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
|
|
US6787532B2
(en)
*
|
2000-08-05 |
2004-09-07 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivatives
|
|
AR032362A1
(es)
|
2000-08-14 |
2003-11-05 |
Glaxo Group Ltd |
Formulacion topica estable de una emulsion de aceite en agua y proceso para su preparacion
|
|
AR037080A1
(es)
|
2000-09-29 |
2004-10-20 |
Glaxo Group Ltd |
Compuestos utiles en el tratamiento de enfermedades inflamatorias,composiciones que los contienen, su uso en terapia, metodos de tratamiento, procesos de preparacion e intermediarios
|
|
EP1333830A2
(de)
|
2000-10-31 |
2003-08-13 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Neue arzneimittelkompositionen auf der basis von anticholingergika und corticosteroiden
|
|
DE10062712A1
(de)
|
2000-12-15 |
2002-06-20 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
|
|
PT1344526E
(pt)
|
2000-12-22 |
2008-06-18 |
Nippon Shinyaku Co Ltd |
Profiláticos/remédios para doenças inflamatórias das vias aéreas
|
|
US20020132803A1
(en)
|
2001-01-05 |
2002-09-19 |
Mahendra Dedhiya |
Fluticasone suspension formulation, spray pattern method, and nasal spray apparatus
|
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
|
ES2288543T3
(es)
|
2001-03-08 |
2008-01-16 |
Glaxo Group Limited |
Agonistas de beta-adrenorreceptores.
|
|
US7045658B2
(en)
|
2001-03-22 |
2006-05-16 |
Glaxo Group Limited |
Formailide derivatives as beta2-adrenoreceptor agonists
|
|
UA77656C2
(en)
|
2001-04-07 |
2007-01-15 |
Glaxo Group Ltd |
S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
|
|
AU2002303425A1
(en)
|
2001-04-24 |
2002-11-05 |
Epigenesis Pharmaceuticals, Inc. |
Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
|
|
WO2002088167A1
(en)
|
2001-04-30 |
2002-11-07 |
Glaxo Group Limited |
Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
|
|
ES2307751T3
(es)
|
2001-06-12 |
2008-12-01 |
Glaxo Group Limited |
Nuevos esteres heterociclicos centi-inflamatorios 17 alfa de derivados 17 beta de carbotioato de androstano.
|
|
US20030018019A1
(en)
*
|
2001-06-23 |
2003-01-23 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
|
|
AU2002321884A1
(en)
|
2001-08-03 |
2003-02-24 |
Smithkline Beecham Corporation |
A method for preparing fluticasone derivatives
|
|
GB0124523D0
(en)
|
2001-10-12 |
2001-12-05 |
Glaxo Group Ltd |
Pharmaceutical combination
|
|
GB0125259D0
(en)
|
2001-10-20 |
2001-12-12 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2003035688A2
(en)
|
2001-10-26 |
2003-05-01 |
Novartis Pharma Gmbh |
Targeted thrombosis by tissue factor polypeptides
|
|
US7189518B2
(en)
|
2001-11-05 |
2007-03-13 |
The Brigham And Women's Hospital, Inc. |
Soluble CD40L(CD154) as a prognostic marker of atherosclerotic diseases
|
|
GB0127160D0
(en)
|
2001-11-12 |
2002-01-02 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2003042229A1
(en)
|
2001-11-12 |
2003-05-22 |
Glaxo Group Limited |
Non-aromatic heterocyclic esters of furan-2-one-esters of 17.beta.-carboxyl or 17.beta.-carbothio glucocorticoids
|
|
WO2003048181A1
(en)
|
2001-12-01 |
2003-06-12 |
Glaxo Group Limited |
17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
|
|
WO2003072592A1
(en)
|
2002-01-15 |
2003-09-04 |
Glaxo Group Limited |
17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
|
|
WO2003062259A2
(en)
|
2002-01-21 |
2003-07-31 |
Glaxo Group Limited |
Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
|
|
GB0202216D0
(en)
|
2002-01-31 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
|
DE10216429A1
(de)
|
2002-04-12 |
2003-10-23 |
Boehringer Ingelheim Pharma |
Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
|
|
JP3691459B2
(ja)
*
|
2002-06-14 |
2005-09-07 |
久光メディカル株式会社 |
粉末状吸入剤組成物
|
|
GB0217504D0
(en)
|
2002-07-29 |
2002-09-04 |
Novartis Ag |
Organic compounds
|
|
US7244742B2
(en)
*
|
2002-08-17 |
2007-07-17 |
Boehringer Ingelheim Pharma Gmbh & Co Kg |
Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
|